ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA
· Real-Time Price · USD
4.47
0.03 (0.68%)
At close: Aug 15, 2025, 12:08 PM
ENDRA Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.04M | -4.15M | -2.35M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M | -2.94M | -3.29M | -3.44M | -3.59M | -2.86M | -3.1M | -2.66M | -3.2M | -2.27M |
Depreciation & Amortization | 45.58K | 46.36K | 54.01K | 50.12K | 55.68K | 61.25K | 70.45K | 72.71K | 71.04K | 67.77K | 58.59K | 55.68K | 52.22K | 53.67K | 61.51K | 60.37K | 48.87K |
Stock-Based Compensation | 83.05K | 104.68K | -36.85K | 186.59K | 317.5K | 250.56K | 252.74K | 255.85K | 237.28K | 290.77K | 309.18K | 311.35K | 288.54K | 411.74K | 136.01 | 112.87 | 368.20 |
Other Working Capital | n/a | 6.42K | 309.87K | -219.83K | 754.00 | 85.13K | 48.09K | -17.75K | -32.1K | -259.96K | 84.97K | 333.53K | 64.26K | -729.65K | -302.87K | 600.67K | 17.59M |
Other Non-Cash Items | n/a | 2.27M | 910.6K | -138.05K | 474.47K | 1.81M | 262.84K | 227.75K | 347.26K | 1.39K | 487.98K | 727.65K | 1.23M | -901.89K | 327.8K | 336.84K | 59.6K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.65M | -262.84K | -227.75K | -347.26K | n/a | -487.98K | -727.65K | n/a | 911.76K | n/a | n/a | n/a |
Change in Working Capital | n/a | 211.13K | -230.91K | 47.18K | 106.67K | -1.19M | 178.89K | -40.03K | 127.58K | -159.02K | -174.38K | -110.94K | -581.42K | -23.38K | -477.82K | 2.49K | -762.68K |
Operating Cash Flow | -1.29M | -1.52M | -1.66M | -2.08M | -2.14M | -2.17M | -2.6M | -2.27M | -2.51M | -3.09M | -3.25M | -3.33M | -3.1M | -2.65M | -2.75M | -2.8M | -2.92M |
Capital Expenditures | -17.28K | n/a | n/a | 11K | -27K | -6.88K | n/a | n/a | -27K | -38.56K | -14.86K | -59.8K | -89.35K | n/a | n/a | n/a | -45K |
Cash Acquisitions | n/a | n/a | -3.2K | n/a | 3.2K | 9.16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 3.2K | 9.16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -17.28K | n/a | n/a | 11K | -23.8K | 2.28K | n/a | n/a | -27K | -38.56K | -14.86K | -59.8K | -89.35K | n/a | n/a | n/a | -45K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | -4.93K | -840 | n/a | n/a | -2.38K | -2.7K | n/a | n/a | -5.09K | -121.07K | n/a | n/a | -121.07K |
Other Financial Acitivies | n/a | n/a | 1.68K | 6.61M | 53.87K | 1.02M | n/a | 20.05K | -2.38K | -7.8M | n/a | n/a | n/a | 121.07K | n/a | n/a | 2.91M |
Financial Cash Flow | 145.8K | n/a | 1.68K | 7.34M | 468.9K | 1.67M | 1.11M | 4.73M | -2.38K | n/a | n/a | 7.55M | 854.05K | 321.08K | 496.61K | n/a | 12.58M |
Net Cash Flow | -1.16M | -1.52M | -1.66M | 5.27M | -1.7M | -500.63K | -1.48M | 2.46M | -2.53M | -3.13M | -3.26M | 4.15M | -2.33M | -2.33M | -2.25M | -2.8M | 9.62M |
Free Cash Flow | -1.31M | -1.52M | -1.66M | -2.07M | -2.17M | -2.18M | -2.6M | -2.27M | -2.53M | -3.13M | -3.26M | -3.39M | -3.19M | -2.65M | -2.75M | -2.8M | -2.97M |